A study by Triton Market Research with the title ‘Global Influenza Vaccines Market,’ covers the Global Analysis and Forecast for 2019-2028 by Technology (Egg-based, Cell-based), Delivery Mode (Injection, Nasal Spray), Type (Trivalent Vaccine, Quadrivalent Vaccine), Age-Group (Pediatric, Adult Age), and by Geographical Region (Europe, North America, Middle East and Africa, Asia-Pacific, Latin America).
Request Free Sample of the Global Influenza Vaccines Market Report @ https://www.tritonmarketresearch.com/reports/influenza-vaccines-market#request-free-sample
Influenza is a contagious viral infection that affects the upper or lower respiratory tract. Influenza vaccines are used to prevent the possibility of an attack by this virus.
According to the report, the global influenza vaccines market is estimated to generate $7070.90 million by the year 2028, expanding with a CAGR of 6.20% during the projected period between 2019 and 2028.
Rapid technological advancements are primarily driving the global influenza vaccines market growth. The government is undertaking several immunization programs to increase awareness among the people towards vaccination. For instance, the Centre for Disease Control and Prevention (CDC) recommended a vaccination schedule that provides proper information about vaccines. These initiatives are also favoring the market growth. However, the high cost of vaccine development is expected to hamper the growth of the this market.
The influenza vaccines market is segmented into technology, delivery mode, type and age-group. The first segment, technology, is divided into egg-based and cell-based. The second segment, delivery mode, includes injection and nasal spray. The third segment, type, is divided into trivalent vaccine and quadrivalent vaccine. The last segment, age-group, includes pediatric and adult age.
As per the regional landscape, North America will be the largest influenza vaccines market over the forecasted period. The rising number of deaths and hospitalizations due to influenza in countries like the United States and Canada is primarily driving the need for influenza vaccines market. Vaccine doses are recommended by government bodies like the US Department of Health and Human Services, and this is likely to be another driving factor for the regional market growth.
Some of the key players in the influenza vaccines market are Merck Sharp & Dohme Corp, Pfizer Inc, F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, Emergent Biosolutions Inc, Abbott, BioDiem, Sanofi, CSL Limited and Novartis AG.
Purchase this Report @ https://www.tritonmarketresearch.com/reports/influenza-vaccines-market#purchase-option
Question & Answer: Influenza Vaccines Market
Question 1: Which factors are driving the global influenza vaccines market growth?
Answer: Rapid technological advancements are primarily driving the global influenza vaccines market growth. The government is undertaking several immunization programs to increase awareness among the people towards vaccination. For instance, the Centre for Disease Control and Prevention (CDC) recommended a vaccination schedule that provides proper information about vaccines. These initiatives are also favoring the market growth.
Question 2: What is expected to hamper the growth of the global influenza vaccines market?
Answer: The high cost of vaccine development is expected to hamper the growth of the influenza vaccines market.
Question 3: How is North America influencing the influenza vaccines market outlook?
Answer: As per the regional landscape, North America will be the largest influenza vaccines market over the forecasted period. The rising number of deaths and hospitalizations due to influenza in countries like the United States and Canada is primarily driving the need for influenza vaccines market. Vaccine doses are recommended by government bodies like the US Department of Health and Human Services and this is likely to be another driving factor for the regional market growth.
Question 4: Which are the key players mentioned in the competitive landscape of the influenza vaccines market report?
Answer: Some of the key players in the Influenza Vaccines market are Merck Sharp & Dohme Corp, Pfizer Inc, F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, Emergent Biosolutions Inc, Abbott, BioDiem, Sanofi, CSL Limited and Novartis AG.
Related Report:
The Global DNA Vaccines Market is estimated to exhibit growth at $37.384 billion by the year 2027, with a CAGR of 42.03% over the forecasted years 2019-2027.
Gene therapies are techniques that make use of genes to prevent or treat diseases. Instead of using drugs or surgery, gene therapy allows doctors to insert a gene in the cell of patients to treat them. It finds applications in the treatment of diseases like HIV, cancer, retinal eye diseases and others. The growing demand for gene therapy is likely to create an opportunity for the DNA vaccines market.
In conventional vaccines, maintaining the potency of viruses is the biggest challenge, as they have to be refrigerated from the time of development to administration. About 80% of the vaccination development cost is due to the cold-chain problem. Since DNA vaccines are easy to store due to their stability, they are more advantageous than others. Unlike traditional methods, these are non-infectious and incapable of replication. DNA vaccines for cancer treatment have been undergoing preclinical and clinical trials. They are now considered to be an effective treatment method for various diseases. The increasing number of clinical trials on human beings is aiding the global DNA vaccine market growth.
Media Contact
Company Name: Triton Market Research
Contact Person: Matt Dixson
Email: Send Email
Phone: +44 7441 911839
Address:196, wards wharf approach London E16 2EQ
Country: United Kingdom
Website: https://www.tritonmarketresearch.com/